Tim W.H. Chan
Direktor/Vorstandsmitglied bei Augurex Life Sciences Corp.
Profil
Tim W.H.
Chan is currently a Director at Augurex Life Sciences Corp.
Prior to this, he worked as a Portfolio Manager at Phillips, Hager & North Investment Management from 1996 to 2008.
He received his undergraduate degree from the University of British Columbia in 1985.
Aktive Positionen von Tim W.H. Chan
Unternehmen | Position | Beginn |
---|---|---|
Augurex Life Sciences Corp.
Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Tim W.H. Chan
Unternehmen | Position | Ende |
---|---|---|
Phillips, Hager & North Investment Management
Phillips, Hager & North Investment Management Financial ConglomeratesFinance Founded in 1964 by Art Phillips, Bob Hager and Rudy North, Phillips, Hager & North Investment Management (PH&N) is an investment advisor headquartered in Vancouver, British Columbia. The firm is an operating division of RBC Global Asset Management (RBC GAM), itself a wholly-owned subsidiary of the Royal Bank of Canada (NYSE: RY) which acquired PH&N in May 2008. In November 2010, PH&N amalgamated with their affiliate, RBC Asset Management, Inc. to form RBC GAM. RBC GAM is the fund manager and principal portfolio advisor of the PH&N Funds and the BonaVista Funds. The primary distributor of the PH&N Funds and the BonaVista Funds is Phillips, Hager & North Investments Funds Ltd., dba PH&N Investment services, | Portfolio Manager-Aktien | 30.09.2008 |
Ausbildung von Tim W.H. Chan
University of British Columbia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Phillips, Hager & North Investment Management
Phillips, Hager & North Investment Management Financial ConglomeratesFinance Founded in 1964 by Art Phillips, Bob Hager and Rudy North, Phillips, Hager & North Investment Management (PH&N) is an investment advisor headquartered in Vancouver, British Columbia. The firm is an operating division of RBC Global Asset Management (RBC GAM), itself a wholly-owned subsidiary of the Royal Bank of Canada (NYSE: RY) which acquired PH&N in May 2008. In November 2010, PH&N amalgamated with their affiliate, RBC Asset Management, Inc. to form RBC GAM. RBC GAM is the fund manager and principal portfolio advisor of the PH&N Funds and the BonaVista Funds. The primary distributor of the PH&N Funds and the BonaVista Funds is Phillips, Hager & North Investments Funds Ltd., dba PH&N Investment services, | Finance |
Augurex Life Sciences Corp.
Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | Health Technology |